- Home
- FGB vs CPIX Comparison
FGB vs CPIX Comparison
Compare FGB & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGB
- CPIX
- Stock Information
- Founded
- FGB 2007
- CPIX 1999
- Country
- FGB United States
- CPIX United States
- Employees
- FGB N/A
- CPIX N/A
- Industry
- FGB Finance/Investors Services
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- FGB Finance
- CPIX Health Care
- Exchange
- FGB Nasdaq
- CPIX Nasdaq
- Market Cap
- FGB 60.1M
- CPIX 68.7M
- IPO Year
- FGB N/A
- CPIX 2009
- Fundamental
- Price
- FGB $3.85
- CPIX $4.76
- Analyst Decision
- FGB
- CPIX
- Analyst Count
- FGB 0
- CPIX 0
- Target Price
- FGB N/A
- CPIX N/A
- AVG Volume (30 Days)
- FGB 53.0K
- CPIX 43.3K
- Earning Date
- FGB 01-01-0001
- CPIX 05-06-2025
- Dividend Yield
- FGB 8.92%
- CPIX N/A
- EPS Growth
- FGB N/A
- CPIX N/A
- EPS
- FGB N/A
- CPIX N/A
- Revenue
- FGB N/A
- CPIX $37,867,945.00
- Revenue This Year
- FGB N/A
- CPIX N/A
- Revenue Next Year
- FGB N/A
- CPIX N/A
- P/E Ratio
- FGB N/A
- CPIX N/A
- Revenue Growth
- FGB N/A
- CPIX N/A
- 52 Week Low
- FGB $2.85
- CPIX $1.04
- 52 Week High
- FGB $3.74
- CPIX $7.25
- Technical
- Relative Strength Index (RSI)
- FGB 40.41
- CPIX 56.04
- Support Level
- FGB $3.61
- CPIX $3.98
- Resistance Level
- FGB $3.83
- CPIX $4.41
- Average True Range (ATR)
- FGB 0.16
- CPIX 0.30
- MACD
- FGB -0.01
- CPIX 0.06
- Stochastic Oscillator
- FGB 48.42
- CPIX 98.00
About FGB First Trust Specialty Finance and Financial Opportunities Fund
First Trust Specialty Fnc & Fncl Oppor is a United States-based closed-end management investment company. The Fund's primary investment objective is to seek a high level of current income. It seeks a positive total return as a secondary objective. The Fund seeks to achieve its investment objectives by investing at least 80% of its Managed Assets in a portfolio of securities of specialty finance and other financial companies.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.